Five things for pharma marketers to know:
- Disgraced Theranos founder Elizabeth Holmes’ prison sentence was shortened by two years, according to federal records.
- The European Medicines Agency said it has extended its probe into Novo Nordisk’s diabetes drug Ozempic and weight-loss treatment Saxenda following two reports of suicidal thoughts to include other drugs in the same class.
- Astellas Pharma and 4D Molecular Therapeutics announced a rare eye disease licensing deal that could be worth up to $962 million.
- The Food and Drug Administration classified its recall of certain Johnson & Johnson electrosurgery tools as the most serious.
- In recent weeks, three closely-watched FDA decisions came in positive for the companies – followed by their stocks going negative.
